Secondary Logo

Journal Logo

June 2022 - Volume 47 - Issue 6
pp: 473-568,e428-e474

Prognostic Potential of Postoperative 18F-Fluorocholine PET/CT in Patients With High-Grade Glioma. Clinical Validation of FuMeGA Postoperative PET Criteria

García Vicente, Ana María; Pena Pardo, Francisco José; Amo-Salas, Mariano; More

Clinical Nuclear Medicine. 47(6):480-487, June 2022.

Detecting Interval Distant Metastases With 18F-FDG PET/CT After Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Cancer

Kroese, Tiuri E.; Ruurda, Jelle P.; Bakker, Anne S.; More

Clinical Nuclear Medicine. 47(6):496-502, June 2022.

ACR-ACNM-ASTRO-SNMMI Practice Parameter for Lutetium-177 (Lu-177) DOTATATE Therapy

Love, Charito; Desai, Neil B.; Abraham, Tony; More

Clinical Nuclear Medicine. 47(6):503-511, June 2022.

Interobserver Agreement Rates on Fibroblast Activation Protein Inhibitor–Directed Molecular Imaging and Therapy

Serfling, Sebastian E.; Hartrampf, Philipp E.; Zhi, Yingjun; More

Clinical Nuclear Medicine. 47(6):512-516, June 2022.

Role of Dynamic Parameters of 18F-DOPA PET/CT in Pediatric Gliomas

Fiz, Francesco; Bini, Fabiano; Gabriele, Edoardo; More

Clinical Nuclear Medicine. 47(6):517-524, June 2022.

18F-FDG PET/CT May Predict Tumor Type and Risk Score in Gestational Trophoblastic Disease

Bezzi, Carolina; Monaco, Lavinia; Ghezzo, Samuele; More

Clinical Nuclear Medicine. 47(6):525-531, June 2022.

Amino Acid Uptake, Glucose Metabolism, and Neuroinflammation in John Cunningham Virus Associated Progressive Multifocal Leukoencephalopathy

Unterrainer, Marcus; Mahler, Christoph; Schumacher, Adrian-Minh; More

Clinical Nuclear Medicine. 47(6):543-544, June 2022.

First-in-Human Experience With 177Lu-DOTAGA.(SA.FAPi)2 Therapy in an Uncommon Case of Aggressive Medullary Thyroid Carcinoma Clinically Mimicking as Anaplastic Thyroid Cancer

Ballal, Sanjana; Yadav, Madhav Prasad; Moon, Euy Sung; More

Clinical Nuclear Medicine. 47(6):e444-e445, June 2022.